Android app on Google Play

Roth Capital Downgrades Peregrine Pharmaceuticals (PPHM) to Neutral

September 24, 2012 9:19 AM EDT Send to a Friend
Get Alerts PPHM Hot Sheet
Price: $1.56 -1.27%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 15 | Down: 38 | New: 6
Trade PPHM Now!
Join SI Premium – FREE
Roth Capital downgraded Peregrine Pharmaceuticals (NASDAQ: PPHM) from Buy to Neutral with a price target of $0.70 (from $9.00).

For an analyst ratings summary and ratings history on Peregrine Pharmaceuticals click here. For more ratings news on Peregrine Pharmaceuticals click here.

Shares of Peregrine Pharmaceuticals closed at $5.39 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Roth Capital

Add Your Comment